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Abstract
Purpose The optimal postoperative analgesia after cesarean section (CS) remains to be determined. The primary objective 
of this study was to assess whether oral oxycodone provides the same or better pain control and satisfaction with pain relief 
as oxycodone given intravenously using a patient-controlled analgesia (PCA) infusion device. The secondary objectives were 
to compare the gastrointestinal symptoms and postsurgical recovery of the two groups.
Methods This prospective randomized trial was conducted at a University Hospital between February 2015 and June 2017. 
Altogether 270 CS patients were randomly assigned to receive postoperative oxycodone pain relief by IV PCA (n = 133) or 
orally (n = 137). Pain control and satisfaction with pain treatment were assessed by a numeric rating scale (NRS) at 2, 4, 8, 
and 24 h postoperatively.
Results No differences were found in NRS pain scores or satisfaction between the groups except at 24 h pain when cough-
ing; there was a statistically significant difference favoring the IV PCA group (p = 0.006). In the IV PCA group, the patients 
experienced more nausea at 4 h (p = 0.001) and more vomiting at 8 h (p = 0.010). Otherwise, postoperative recovery was 
similar in both groups. The equianalgesic dose of oxycodone was significantly smaller in the oral group (p = 0.003).
Conclusions This study indicates that oral oxycodone provides pain control and satisfaction with pain relief equal to IV 
oxycodone PCA for postoperative analgesia after cesarean section. Satisfaction with pain treatment was high in both groups, 
and both methods were well tolerated. Early nausea was less common with oral medication.
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Abbreviations
CS  Cesarean section
NRS  Numeric rating scale
PCA  Patient-controlled analgesia
NCA  Nurse-controlled analgesia
IV  Intravenous
IM  Intramuscular
VAS  Visual analogue scale
OX/NAL  Extended-release oxycodone/naloxone tablet
Introduction
Cesarean section (CS) is one of the most common surgi-
cal operations in the world [1]. In some countries, the CS 
rate reaches over 40% [2, 3]. In Finland, the CS rate has 
remained low at about 16.7% [4]. Pain relief after CS is cru-
cial, and it affects both the mother and child. Poor pain relief 
may adversely affect recovery, mother–infant bonding, and 
breast-feeding; it may even lead to persistent postsurgical 
pain. Pain after CS was ranked ninth for pain severity among 
179 surgical procedures in a study of 115,775 patients [5]. 
There are variable methods to manage postoperative pain, 
and the search for the ideal method is still ongoing. The use 
of opioids via different routes is the gold standard, although 
several other techniques have also been proposed [6].
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After CS, patients usually need opioid analgesia for 
1–2 days. Intrathecal, epidural, intravenous (IV), intramus-
cular (IM), subcutaneous, or oral routes and a continuous or 
intermittent manner of dosing can be used [7]. In addition to 
opioids, patients are given anti-inflammatory analgesics to 
promote better pain relief. The results of studies comparing 
different methods for pain relief after surgical interventions 
are controversial [8].
Neuraxial or IV morphine is considered the standard 
choice of opioid for post-CS pain [9]. IV oxycodone has 
gained increasing popularity of late due to its faster onset of 
action, fewer or less severe adverse events, and better effects 
for visceral pain [10]. Oxycodone has good oral bioavailabil-
ity and a longer duration of action compared to morphine, 
thus making it a good choice for per oral pain relief [11]. 
A recent review of oral oxycodone for acute postoperative 
surgery showed that when administered as part of a multi-
modal analgesic regimen, it produces superior pain relief 
with fewer side effects and lower costs compared to epidural 
and IV analgesics [12].
In our institution, both oral and IV patient-controlled 
analgesia (PCA)-based pain relief are used. Our primary 
goal was to investigate by randomized controlled trial 
whether orally administered oxycodone provides pain con-
trol that is equal to or better than IV PCA oxycodone in CS 
patients. Our secondary objectives were to compare gastro-
intestinal symptoms and postsurgical recovery between the 
groups.
Materials and methods
This prospective randomized study was conducted at the 
Department of Obstetrics and Gynaecology at Tampere 
University Hospital, Finland, between February 2015 and 
June 2017. During the study period, 1637 cesarean sections 
were conducted at the study hospital. The study protocol was 
approved by Pirkanmaa Hospital District’s ethics committee 
(Decision R 14090M, October 13, 2014).
We sought to recruit women scheduled for elective or 
acute CS. Patients who underwent emergency CS or were 
unable to understand the Finnish language were excluded. 
Overall, 270 patients were randomized, 133 into the PCA 
group and 137 into the oral analgesia group. A flowchart of 
the recruitment process is shown in Fig. 1.
Patients were recruited to the study either in the out-
patient clinic when the elective CS was arranged or in the 
delivery room when the decision for the acute CS was made. 
A written information letter and an oral explanation were 
given to the patients, and written consent was requested. 
A research nurse not participating in the treatment of the 
patients prepared envelopes including the information that 
assigned the patient to the IV PCA or oral group. A sealed 
opaque envelope was opened in the operating room by the 
operative nurse.
All patients were operated on under spinal anaesthesia. 
Spinal anaesthesia was performed using a 27-gauge BD™ 
Quincke spinal needle at the L3–4 level. The patients were 
given intrathecal 0.5% hyperbaric bupivacaine 11 mg and 
fentanyl 10 µg. Non-invasive arterial blood pressure was 
maintained above − 10% of the preoperative value using an 
intravenous crystalloid fluid infusion and boluses of intra-
venous phenylepinephrine 0.05 mg.
The patients had either a Pfannenstiel incision (263 
patients) or a lower midline incision (3 patients in the IV 
PCA group and 4 in oral group).
Patients in both groups received extended-release oxy-
codone/naloxone 10/5 mg (OX/NAL) (oxycodone hydro-
chloride 10 mg + naloxone hydrochloride 5 mg), ibuprofen 
600 mg, and paracetamol 1 g orally 1 h after surgery. There-
after, an OX/NAL dose was given every 12 h, and ibuprofen 
and paracetamol were given every 8 h.
In the IV PCA group, the patients received an intravenous 
PCA device (CADD Legacy PCA, Smiths Medical MD, Inc., 
St. Paul, MN, USA) with oxycodone 1 mg/ml, using oxy-
codone bolus doses of 2 mg and a lockout time of 10 min. 
Patients were taught to use the pump in the operating theatre, 
and they were recommended to use it for at least 24 h.
In the oral analgesia group, patients were given an oxyco-
done 5 mg capsule upon request, the maximum dose being 
60 mg in 24 h. The postoperative medication protocol is 
shown in Fig. 2.
Maternal pain scores and satisfaction with pain relief were 
asked and documented on the maternity ward. A numeric 
rating scale (NRS) was used. Pain and satisfaction were rated 
at 2, 4, 8, and 24 h after surgery. The pain scale ranged from 
0 (= no pain) to 10 (= worst pain imaginable), and the satis-
faction scale ranged from 0 (= completely dissatisfied) to 10 
(= completely satisfied). Furthermore, the patient’s subjec-
tive perception about gastrointestinal symptoms—such as 
nausea, vomiting, and abdominal distension—was asked at 
4, 8, and 24 h after surgery and categorized into two groups: 
patients with no symptoms and patients with symptoms. The 
time point for mobilization, the first meal, and defecation 
was recorded as well.
The equianalgesic dose ratio between intravenous and 
oral oxycodone has been reported to be 1:2 [13, 14]; this 
ratio was therefore used to calculate the equianalgesic dose 
of oral oxycodone for the two groups.
Statistical analysis
Based on previous studies [15], the sample size calculations 
were made with the assumption that the standard deviations 
in pain scores would be 1.4, and a score difference between 
the groups of 0.5 would be regarded as clinically significant. 
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With these assumptions, the sample size analysis indicated 
that 123 patients in each group would be sufficient.
Statistics were analysed using SPSS for Windows, version 
22.0 (IBM Corp., Armonk, NY, USA, 2013). Variables were 
tested for normality using the Shapiro–Wilk and Kolmogo-
rov–Smirnov tests. Differences in continuous variables were 
studied using Student’s t test in cases of normality and by 
the Mann–Whitney U test in cases of skewed distribution. 
Categorical data are presented as percentages. They were 
compared using the Chi-square test or Fisher’s exact test, 
where appropriate. Intention to treat analyses was made by 
groups.
Results
In total, 221 patients after elective CS and 49 patients after 
acute CS were enrolled in the study. The groups did not dif-
fer by characteristics regarding maternal background or the 
type of operation (Table 1).
Two patients in the IV PCA group needed general anes-
thesia during CS, one because of inadequate anesthesia 
and the other because of heavy bleeding during the opera-
tion. All other study patients were operated on under spinal 
anesthesia.
Five patients requested to have the IV PCA discontin-
ued after a few hours’ use because of side effects like nau-
sea. Respectively, six patients in the oral analgesia group 
switched to an IV PCA later on because of pain. Epidural 
analgesia was used for one patient in the IV PCA group, and 
two patients in the IV PCA group were given extra oxyco-
done for intolerable pain. The mean usage time of the IV 
PCA was 19 h postoperatively.
There were no differences in pain at rest or satisfaction 
between the groups at 2, 4, 8, and 24 h postoperatively, nor 
in pain when coughing at 2, 4, and 8 h postoperatively. At 
24 h, the NRS for pain at coughing was higher in the oral 
group (p = 0.006; Fig. 3a–c).
To determine the most discontented patients in the 
groups, the proportions of women with severe pain 
(NRS ≥ 7) and dissatisfaction with pain treatment 
Fig. 1  Distribution of patients 
during the study period
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(NRS ≤ 3) were defined. At 24 h after CS, five patients 
suffered severe pain at rest in the IV PCA group, compared 
to none in the oral group (p = 0.026). No other differences 
were found between the groups either in the experience 
of severe pain or in dissatisfaction with pain treatment 
(Table 2). Overall satisfaction (NRS ≥ 7) for pain treat-
ment was high: more than 77% were satisfied at every time 
point. There were no differences in severe pain or satisfac-
tion between elective and acute CS patients.
Patients in the IV PCA group had more nausea at 4 h 
(p = 0.001) and vomited more often at 8 h (p = 0.010). Oth-
erwise, the groups did not differ in terms of gastrointestinal 
symptoms (Table 3). There was no difference in the recov-
ery time of the groups (Table 4).
In the IV PCA group, the mean consumption of iv oxy-
codone was 58.2 mg (SD 23.5), while in the oral group, the 
mean counted equianalgesic dose was 48.3 mg (SD 11.8) 
during the first 24 h (p = 0.003).
Discussion
In this prospective randomized study, we found that oral oxy-
codone was an equally effective and satisfactory means for 
postoperative analgesia after uncomplicated cesarean section 
as IV oxycodone administered by a patient-controlled device 
(PCA). However, nausea and vomiting were slightly more 
common in patients receiving IV PCA. Regarding postop-
erative pain scores and general satisfaction with pain relief, 
both methods were equally accepted by the patients. The 
results of our study are in line with those of Dieterich et al., 
who randomized 239 patients to receive either intravenous 
opioid piritramide (PCA) or oral oxycodone [16]. They used 
a visual pain scale (VAS) for pain assessment and found 
no differences between the groups. General satisfaction was 
also high, and Dieterich et al.’s results support the use of 
oral pain treatment after CS. Davis et al. also found that oral 
analgesia with oxycodone and acetaminophen after CS gave 
better pain relief with fewer side effects than an IV morphine 
PCA [17]. To our knowledge, no earlier studies comparing 
the per oral and IV PCA administration of oxycodone for 
post-cesarean pain and patient satisfaction exist.
Although alternative drugs, new combinations of existing 
drugs, and new applications of local anesthetics have been 
studied intensively, opioids are still required for post-cesar-
ean analgesia [9]. Intravenous oxycodone is comparable to 
other IV opioids in terms of safety and efficacy [10], but 
even short-term opioid use by patients undergoing surgery 
can lead to chronic opioid use [18]. It is generally known 






doses of 2 mg and 
a lockout me of 
10 min
All study paents
OX/NAL* 10/5 mg 
x 2
Ibuprofein 600 mg 
x 3
Paracetamol 1 g x 
3 per orally
Oral group
oxycodone 5 mg 
tablet by a nurse,   
the maximum dose 
being 60 mg in 24 
hours
Fig. 2  Postoperative medication protocol for the first 24 h after CS
Table 1  Demographic data 
and parameters concerning 
the mother, pregnancy, and 
operation
Values are expressed as the median or number of patients in the group and the parameter variables are 
expressed as the minimum to maximum or percentage in the group
Characteristic IV PCA group, n = 133 Oral group, n = 137
Median/n Min–max/% Median/n Min–max/%
Age (years) 32 19–46 33 20–43
BMI (kg/m2) 23.6 16.2–49.5 24.6 17.5–52.6
Primipara 67 50.4 63 46.0
Gestational age at birth (days) 274 208–295 274 228–295
Full-term > 37 weeks 121 91.0 128 93.4
Prior CS 48 36.1 53 38.7
Elective CS 107 80.5 114 83.2
Operation time (min) 35 15–80 33 15–75
Bleeding (ml) 500 80–4600 450 100–3000
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that rapidly affecting drugs increase this risk, therefore IV 
administration might be unfavorable. Moreover, the cost of 
the IV PCA, including medicine, infusion liquid and PCA 
device, is about twice as high as the oral medication.
It is challenging to treat postoperative pain efficiently 
without side effects. Especially after CS, one must consider 
not only the pain relief and wellbeing of the mother, but also 
active mother–child bonding and breast-feeding. It is also 
crucial to take into account the high risk of thromboembo-
lism after CS [19]. Since delayed standing can negatively 
influence these goals, early postoperative mobilization and 
immediate removal of the urinary catheter are recommended 
after CS [20, 21]. Thus, continuous epidural analgesia may 
not be favored, even if it might give excellent pain control. 
Intramuscular injection should be avoided, and transdermal 
opioids are appropriate only for persistent pain.
Self-administration with an IV PCA is the standard 
treatment in some hospitals, whereas oral administration is 
considered easier and practical in others. Compared to per 
oral administration, patients with an IV PCA can receive a 
drug therapy that is more individualized [22]. They receive 
immediate relief when needed, even for the slightest pain. 
However, unwanted side effects like nausea and drowsiness 
may delay recovery [17]. Per oral administration causes 
fewer side effects, but the pharmacological effect appears 
with a certain delay. Patients are also dependent on nurses, 
who are not always immediately available to deliver oral 
medication upon the patient’s request. Nevertheless, in this 
study, the patients in both groups were equally satisfied with 
the pain relief.
As part of our study protocol, all patients received oral 
ibuprofen and paracetamol regularly every eight hours. 
Combined with the opioid, their safety and opioid-sparing 
effect have been documented in many studies. In the IV 
PCA group, patients used more oxycodone compared to 
the patients in the oral group. Regardless, there were no 
major differences between the groups in terms of the NRS, 
postoperative recovery, or satisfaction. The protocol of 
this study included per oral postoperative extended-release 
oxycodone, which entailed constant oxycodone content for 
all patients. By combining this with a non-steroidal anti-
inflammatory drug and paracetamol regularly, the need for 
short-acting extra oxycodone is considerably lower after 
surgery. This may be the reason why oxycodone adminis-
trated either by an IV PCA or orally ensured equal pain relief 
in our results. As is generally known, all patients usually 
Fig. 3  a Pain scores at rest at different time points after the opera-
tion (0 = no pain, 10 = the worst pain imaginable). b Pain scores when 
coughing at different time points after the operation (0 = no pain, 
10 = the worst pain imaginable). c Satisfaction with pain relief at 
different time points after the operation (0 = completely dissatisfied, 
10 = completely satisfied)
▸
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benefit from participating in a clinical trial, regardless of 
the randomization.
When using an IV PCA, patients may have more nausea 
and drowsiness than with per oral analgesia [17], and this 
can negatively affect mobilization and baby care. Overall, 
nausea and vomiting after CS were rare events in our study 
compared to the study of Kim et al., where 127 patients 
had either an oxycodone or fentanyl IV PCA after a laparo-
scopic supracervical hysterectomy. Oxycodone was associ-
ated with superior analgesia, but those patients had a signifi-
cantly higher incidence of side effects, such as postoperative 
nausea and vomiting, dizziness, and drowsiness [23]. In our 
study, over half the patients (n = 155/216) reported abdom-
inal distension 24 h after surgery (no difference between 
study groups). Patients in the PCA group experienced more 
nausea at the 4-hour time point. Postoperative recovery 
was equal in both groups. The mean time of mobilization 
was 17 h, which is an exceptionally long time compared 
to our 6-h recommendation. Postoperatively, the patients 
were given meals depending on the schedule of the ward, 
i.e., the time of operation determined the time that the meal 
was offered. The mean delay was 7 h postoperatively. The 
Cochrane review in 2014 found early postoperative feeding 
after major gynecological surgery to be safe and to enable 
the faster recovery of bowel function, a shorter hospital stay, 
and higher satisfaction [24].
The strengths of this study include the large, randomized, 
non-selected material, and the comparison of two treat-
ments that are normal in clinical use. A potential weakness 
of this study was the relatively low recruitment percentage 
of acute CS patients, which was 19.5% (26/133) in the IV 
PCA group and 16.8% (23/137) in the oral group. The differ-
ence between pain relief and postoperative recovery between 
the elective and acute CS could not be reliably estimated.
In conclusion, the results of this study show that oral 
oxycodone is an effective and satisfactory method for post-
operative analgesia after cesarean section. IV oxycodone 
administered with the use of a PCA did not offer clinically 
significant benefits. Both methods were generally well tol-
erated, and pain relief was good with both methods. Early 
nausea was less common with oral medication. Therefore, 
our findings do not support the routine use of a IV oxyco-
done PCA in this patient group.
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Table 2  Severe pain (NRS ≥ 7) and dissatisfaction (NRS ≤ 3) at dif-
ferent time points





Time % n % n
Severe pain at rest
 2 h 8 10/119 3 4/124 0.083
 4 h 21 26/123 24 30/126 0.614
 8 h 8 9/120 7 8/121 0.788
 24 h 5 5/106 0 0/111 0.026
Severe pain when coughing
 2 h 20 24/119 12 14/119 0.077
 4 h 43 51/119 52 62/119 0.153
 8 h 38 43/113 36 42/116 0.772
 24 h 17 18/103 25 27/109 0.194
Dissatisfaction with pain treatment
 2 h 5 6/115 5 6/118 0.963
 4 h 4 4/111 6 7/119 0.418
 8 h 3 3/118 8 9/117 0.073
 24 h 3 3/103 1 1/108 0.360
Table 3  Gastrointestinal symptoms at different time points after CS 
in the two groups






Time % n % n
Nausea 4 h 16 19/121 3 4/125 0.001
Nausea 8 h 9 11/121 5 6/120 0.215
Nausea 24 h 5 5/105 6 6/110 0.818
Vomiting 4 h 6 6/105 2 2/109 0.165
Vomiting 8 h 10 11/108 2 2/108 0.010
Vomiting 24 h 4 4/94 0 0/97 0.057
Abdominal distension 4 h 18 21/117 15 18/123 0.487
Abdominal distension 8 h 36 43/119 42 49/119 0.424
Abdominal distension 24 h 70 73/105 74 82/111 0.478
Table 4  Parameters concerning postoperative recovery expressed in 
hours
Characteristic IV PCA group, 
n = 133
Oral group, n = 137 p value
Mean SD Mean SD
First meal 7.8 5.5 7.0 4.6 0.336
Mobilization 17.4 7.4 17.8 6.7 0.567
Defecation 60.1 18.3 59.9 17.5 0.945
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